Search

Search Results
Results 3201 - 3210 of 3322 for wound care
  • Wyeth gets FDA approval for a novel protein device that enhances bone healing
    News - 3 May 2004
    Wyeth have announced that the FDA has approved rhBMP-2/ACS (recombinant human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge), a novel protein device that enhances bone healing, for use in...
  • Arava
    Drug - 21 Oct 2025
    Consumer Medicine Information (CMI) about Arava intended for persons living in Australia.
  • Azith
    Drug - 20 Oct 2025
    Consumer Medicine Information (CMI) about Azith intended for persons living in Australia.
  • Azithromycin Viatris
    Drug - 20 Oct 2025
    Consumer Medicine Information (CMI) about Azithromycin Viatris intended for persons living in Australia.
  • Trulicity
    Drug - 20 Oct 2025
    Consumer Medicine Information (CMI) about Trulicity intended for persons living in Australia.
  • Nepiten
    Drug - 20 Oct 2025
    Consumer Medicine Information (CMI) about Nepiten intended for persons living in Australia.
  • Hexaxim
    Drug - 16 Oct 2025
    Consumer Medicine Information (CMI) about Hexaxim intended for persons living in Australia.
  • Bijuva 1/100
    Drug - 13 Oct 2025
    Consumer Medicine Information (CMI) about Bijuva 1/100 intended for persons living in Australia.
  • Cabometyx
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Cabometyx intended for persons living in Australia.
  • Numit 5% cream
    Drug - 8 Oct 2025
    Consumer Medicine Information (CMI) about Numit 5% cream intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback